Literature DB >> 10604476

A novel nuclear export activity in HIV-1 matrix protein required for viral replication.

S Dupont1, N Sharova, C DéHoratius, C M Virbasius, X Zhu, A G Bukrinskaya, M Stevenson, M R Green.   

Abstract

An important aspect of the pathophysiology of human immunodeficiency virus type-1 (HIV-1) infection is the ability of the virus to replicate in non-dividing cells. HIV-1 matrix (MA), the amino-terminal domain of the Pr55 gag polyprotein (Pr55), bears a nuclear localization signal that promotes localization of the viral preintegration complex to the nucleus of non-dividing cells following virus entry. However, late during infection, MA, as part of Pr55, directs unspliced viral RNA to the plasma membrane, the site of virus assembly. How MA can mediate these two opposing targeting functions is not understood. Here we demonstrate that MA has a previously undescribed nuclear export activity. Although MA lacks the canonical leucine-rich nuclear export signal, nuclear export is mediated through the conserved Crm1p pathway and functions in both mammalian cells and yeast. A mutation that disrupts the MA nuclear export signal (MA-M4) mislocalizes Pr55 and genomic viral RNA to the nucleus, thereby severely impairing viral replication. Furthermore, we show that MA-M4 can act in a dominant-negative fashion to mislocalize genomic viral RNA even in the presence of wild-type MA. We conclude that the MA nuclear export signal is required to counteract the MA nuclear localization signal, thus ensuring the cytoplasmic availability of the components required for virion assembly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604476     DOI: 10.1038/45272

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

Review 1.  Transport into and out of the nucleus.

Authors:  I G Macara
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

2.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.

Authors:  Lisa Z Scheifele; Rachel A Garbitt; Jonathan D Rhoads; Leslie J Parent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions.

Authors:  K Gupta; D Ott; T J Hope; R F Siliciano; J D Boeke
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Entropic switch regulates myristate exposure in the HIV-1 matrix protein.

Authors:  Chun Tang; Erin Loeliger; Paz Luncsford; Isaac Kinde; Dorothy Beckett; Michael F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

5.  hRIP, a cellular cofactor for Rev function, promotes release of HIV RNAs from the perinuclear region.

Authors:  Nuria Sánchez-Velar; Enyeneama B Udofia; Zhong Yu; Maria L Zapp
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

6.  Link between genome packaging and rate of budding for Rous sarcoma virus.

Authors:  Eric M Callahan; John W Wills
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.

Authors:  Zhibin Wu; Jerry Alexandratos; Bryan Ericksen; Jacek Lubkowski; Robert C Gallo; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

8.  CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins.

Authors:  Chungwon Chung; Robert H Mealey; Travis C McGuire
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

9.  Value of MR contrast media in image-guided body interventions.

Authors:  Maythem Saeed; Mark Wilson
Journal:  World J Radiol       Date:  2012-01-28

Review 10.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.